VMP 42292711000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Bumetanide 5mg tablets
BNF code 0202020D0AAAFAF
Virtual Therapeutic Moiety Bumetanide
Date identifier became valid 29 Sep 2023
Previous product identifier 318022002
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Bumetanide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 5.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Bumetanide 5mg tablets (A A H Pharmaceuticals Ltd)
Bumetanide 5mg tablets (Alliance Healthcare (Distribution) Ltd)
Bumetanide 5mg tablets (Imported)
Bumetanide 5mg tablets (Medihealth (Northern) Ltd)
Bumetanide 5mg tablets (Phoenix Healthcare Distribution Ltd)
Bumetanide 5mg tablets (Sigma Pharmaceuticals Plc)
Bumetanide 5mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Bumetanide 5mg tablets 28 tablet
Bumetanide 5mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.

Feedback